-
1
-
-
29144508843
-
Global prevalence of dementia: A Delphi consensus study
-
DOI 10.1016/S0140-6736(05)67889-0, PII S0140673605678890
-
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112-2117. (Pubitemid 41797645)
-
(2005)
Lancet
, vol.366
, Issue.9503
, pp. 2112-2117
-
-
Ferri, C.P.1
Prince, M.2
Brayne, C.3
Brodaty, H.4
Fratiglioni, L.5
Ganguli, M.6
Hall, K.7
Hasegawa, K.8
Hendrie, H.9
Huang, Y.10
Jorm, A.11
Mathers, C.12
Menezes, P.R.13
Rimmer, E.14
Scazufca, M.15
-
2
-
-
84862995971
-
The French series of autosomal dominant early onset Alzheimer's disease cases: Mutation spectrum and cerebrospinal fluid biomarkers
-
Wallon D, Rousseau S, Rovelet-Lecrux A, Quillard-Muraine M, Guyant-Marechal L, Martinaud O, Pariente J, Puel M, Rollin-Sillaire A, Pasquier F, Le Ber I, Sarazin M, Croisile B, Boutoleau-Bretonniere C, Thomas-Anterion C, Paquet C, Moreaud O, Gabelle A, Sellal F, Sauvee M, Laquerriere A, Duyckaerts C, Delisle MB, Streichenberger N, Lannes B, Frebourg T, Hannequin D, Campion D (2012) The French series of autosomal dominant early onset Alzheimer's disease cases: Mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis 30, 847-856.
-
(2012)
J Alzheimers Dis
, vol.30
, pp. 847-856
-
-
Wallon, D.1
Rousseau, S.2
Rovelet-Lecrux, A.3
Quillard-Muraine, M.4
Guyant-Marechal, L.5
Martinaud, O.6
Pariente, J.7
Puel, M.8
Rollin-Sillaire, A.9
Pasquier, F.10
Le Ber, I.11
Sarazin, M.12
Croisile, B.13
Boutoleau-Bretonniere, C.14
Thomas-Anterion, C.15
Paquet, C.16
Moreaud, O.17
Gabelle, A.18
Sellal, F.19
Sauvee, M.20
Laquerriere, A.21
Duyckaerts, C.22
Delisle, M.B.23
Streichenberger, N.24
Lannes, B.25
Frebourg, T.26
Hannequin, D.27
Campion, D.28
more..
-
3
-
-
84859498356
-
Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease
-
Mouton-Liger F, Paquet C, Dumurgier J, Lapalus P, Gray F, Laplanche JL, Hugon J (2012) Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease. Biol Psychiatry 71, 829-835.
-
(2012)
Biol Psychiatry
, vol.71
, pp. 829-835
-
-
Mouton-Liger, F.1
Paquet, C.2
Dumurgier, J.3
Lapalus, P.4
Gray, F.5
Laplanche, J.L.6
Hugon, J.7
-
4
-
-
84455173823
-
CSF Abeta (1) (-) (4) (2) levels and glucose metabolism in Alzheimer's disease
-
Dumurgier J, Paquet C, Peoc'h K, Lapalus P, Mouton-Liger F, Benisty S, Chasseigneaux S, Chabriat H, Hugon J (2011) CSF Abeta (1) (-) (4) (2) levels and glucose metabolism in Alzheimer's disease. J Alzheimers Dis 27, 845-851.
-
(2011)
J Alzheimers Dis
, vol.27
, pp. 845-851
-
-
Dumurgier, J.1
Paquet, C.2
Peoc'H, K.3
Lapalus, P.4
Mouton-Liger, F.5
Benisty, S.6
Chasseigneaux, S.7
Chabriat, H.8
Hugon, J.9
-
5
-
-
84863945854
-
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes
-
Perret-Liaudet A, Pelpel M, Tholance Y, Dumont B, Vanderstichele H, Zorzi W, Elmoualij B, Schraen S, Moreaud O, Gabelle A, Thouvenot E, Thomas-Anterion C, Touchon J, Krolak-Salmon P, Kovacs GG, Coudreuse A, Quadrio I, Lehmann S (2012) Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes. J Alzheimers Dis 31, 13-20.
-
(2012)
J Alzheimers Dis
, vol.31
, pp. 13-20
-
-
Perret-Liaudet, A.1
Pelpel, M.2
Tholance, Y.3
Dumont, B.4
Vanderstichele, H.5
Zorzi, W.6
Elmoualij, B.7
Schraen, S.8
Moreaud, O.9
Gabelle, A.10
Thouvenot, E.11
Thomas-Anterion, C.12
Touchon, J.13
Krolak-Salmon, P.14
Kovacs, G.G.15
Coudreuse, A.16
Quadrio, I.17
Lehmann, S.18
-
6
-
-
84859354541
-
Cerebrospinal fluid collection tubes: A critical issue for Alzheimer disease diagnosis
-
Perret-Liaudet A, Pelpel M, Tholance Y, Dumont B, Vanderstichele H, Zorzi W, ElMoualij B, Schraen S, Moreaud O, Gabelle A, Thouvenot E, Thomas-Anterion C, Touchon J, Krolak-Salmon P, Kovacs GG, Coudreuse A, Quadrio I, Lehmann S (2012) Cerebrospinal fluid collection tubes: A critical issue for Alzheimer disease diagnosis. Clin Chem 58, 787-789.
-
(2012)
Clin Chem
, vol.58
, pp. 787-789
-
-
Perret-Liaudet, A.1
Pelpel, M.2
Tholance, Y.3
Dumont, B.4
Vanderstichele, H.5
Zorzi, W.6
Elmoualij, B.7
Schraen, S.8
Moreaud, O.9
Gabelle, A.10
Thouvenot, E.11
Thomas-Anterion, C.12
Touchon, J.13
Krolak-Salmon, P.14
Kovacs, G.G.15
Coudreuse, A.16
Quadrio, I.17
Lehmann, S.18
-
7
-
-
80053510055
-
Decreased sAbetaPPbeta, Abeta38, and Abeta40 cerebrospinal fluid levels in frontotemporal dementia
-
Gabelle A, Roche S, Geny C, Bennys K, Labauge P, Tholance Y, Quadrio I, Tiers L, Gor B, Boulanghien J, Chaulet C, Vighetto A, Croisile B, Krolak-Salmon P, Perret-Liaudet A, Touchon J, Lehmann S (2011) Decreased sAbetaPPbeta, Abeta38, and Abeta40 cerebrospinal fluid levels in frontotemporal dementia. J Alzheimers Dis 26, 553-563.
-
(2011)
J Alzheimers Dis
, vol.26
, pp. 553-563
-
-
Gabelle, A.1
Roche, S.2
Geny, C.3
Bennys, K.4
Labauge, P.5
Tholance, Y.6
Quadrio, I.7
Tiers, L.8
Gor, B.9
Boulanghien, J.10
Chaulet, C.11
Vighetto, A.12
Croisile, B.13
Krolak-Salmon, P.14
Perret-Liaudet, A.15
Touchon, J.16
Lehmann, S.17
-
8
-
-
84868195354
-
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria
-
Renard D, Castelnovo G, Wacongne A, Le Floch A, Thouvenot E, Mas J, Gabelle A, Labauge P, Lehmann S (2012) Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol 259, 2429-2433.
-
(2012)
J Neurol
, vol.259
, pp. 2429-2433
-
-
Renard, D.1
Castelnovo, G.2
Wacongne, A.3
Le Floch, A.4
Thouvenot, E.5
Mas, J.6
Gabelle, A.7
Labauge, P.8
Lehmann, S.9
-
9
-
-
84856548921
-
Multicenter study on lumbar puncture indication, clinical practice and feasibility
-
Paquet C, Latour F, Saulnier I, Hanon O (2012) Multicenter study on lumbar puncture indication, clinical practice and feasibility. Rev Neurol (Paris) 168, 28-32.
-
(2012)
Rev Neurol (Paris)
, vol.168
, pp. 28-32
-
-
Paquet, C.1
Latour, F.2
Saulnier, I.3
Hanon, O.4
-
10
-
-
77957267776
-
Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40, and 42 in human cerebrospinal fluid
-
Gabelle A, Roche S, Geny C, Bennys K, Labauge P, Tholance Y, Quadrio I, Tiers L, Gor B, Chaulet C, Vighetto A, Croisile B, Krolak-Salmon P, Touchon J, Perret-Liaudet A, Lehmann S (2010) Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40, and 42 in human cerebrospinal fluid. Brain Res 1357, 175-183.
-
(2010)
Brain Res
, vol.1357
, pp. 175-183
-
-
Gabelle, A.1
Roche, S.2
Geny, C.3
Bennys, K.4
Labauge, P.5
Tholance, Y.6
Quadrio, I.7
Tiers, L.8
Gor, B.9
Chaulet, C.10
Vighetto, A.11
Croisile, B.12
Krolak-Salmon, P.13
Touchon, J.14
Perret-Liaudet, A.15
Lehmann, S.16
-
11
-
-
79957504843
-
Inverse association between CSF Abeta 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory
-
Dumurgier J, Paquet C, Benisty S, Kiffel C, Lidy C, Mouton-Liger F, Chabriat H, Laplanche JL, Hugon J (2010) Inverse association between CSF Abeta 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory. Neurobiol Dis 40, 456-459.
-
(2010)
Neurobiol Dis
, vol.40
, pp. 456-459
-
-
Dumurgier, J.1
Paquet, C.2
Benisty, S.3
Kiffel, C.4
Lidy, C.5
Mouton-Liger, F.6
Chabriat, H.7
Laplanche, J.L.8
Hugon, J.9
-
12
-
-
70349576339
-
Association of plasma amyloid beta with risk of dementia: The prospective Three-City Study
-
Lambert JC, Schraen-Maschke S, Richard F, FievetN, Rouaud O, Berr C, Dartigues JF, Tzourio C, Alperovitch A, Buee L, Amouyel P (2009) Association of plasma amyloid beta with risk of dementia: The prospective Three-City Study. Neurology 73, 847-853.
-
(2009)
Neurology
, vol.73
, pp. 847-853
-
-
Lambert, J.C.1
Schraen-Maschke, S.2
Richard, F.3
Fievet, N.4
Rouaud, O.5
Berr, C.6
Dartigues, J.F.7
Tzourio, C.8
Alperovitch, A.9
Buee, L.10
Amouyel, P.11
-
13
-
-
77952551434
-
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels
-
Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, Bombois S, Brettschneider J, Fox NC, von Arnim CA, Teunissen C, Pijnenburg Y, Riepe MW, Otto M, Tumani H, Scheltens P, Buee L, Rossor MN (2010) An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels. Exp Neurol 223, 432-438.
-
(2010)
Exp Neurol
, vol.223
, pp. 432-438
-
-
Petzold, A.1
Chapman, M.D.2
Schraen, S.3
Verwey, N.A.4
Pasquier, F.5
Bombois, S.6
Brettschneider, J.7
Fox, N.C.8
Von Arnim, C.A.9
Teunissen, C.10
Pijnenburg, Y.11
Riepe, M.W.12
Otto, M.13
Tumani, H.14
Scheltens, P.15
Buee, L.16
Rossor, M.N.17
-
14
-
-
79953737218
-
Molecular actors in Alzheimer's disease: Which diagnostic and therapeutic consequences?
-
Buee L, Blum D, Bombois S, Buee-ScherrerV, Caillet-Boudin ML, Colin M, Deramecourt V, Dhaenens CM, Galas MC, Hamdane M, Humez S, Maurage CA, Pasquier F, Sablonniere B, Schraen-Maschke S, Sergeant N (2010) Molecular actors in Alzheimer's disease: Which diagnostic and therapeutic consequences?. Therapie 65, 401-407.
-
(2010)
Therapie
, vol.65
, pp. 401-407
-
-
Buee, L.1
Blum, D.2
Bombois, S.3
Buee-Scherrer, V.4
Caillet-Boudin, M.L.5
Colin, M.6
Deramecourt, V.7
Dhaenens, C.M.8
Galas, M.C.9
Hamdane, M.10
Humez, S.11
Maurage, C.A.12
Pasquier, F.13
Sablonniere, B.14
Schraen-Maschke, S.15
Sergeant, N.16
-
15
-
-
34447322271
-
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria
-
DOI 10.1016/S1474-4422(07)70178-3, PII S1474442207701783
-
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
-
(2007)
Lancet Neurology
, vol.6
, Issue.8
, pp. 734-746
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
DeKosky, S.T.4
Barberger-Gateau, P.5
Cummings, J.6
Delacourte, A.7
Galasko, D.8
Gauthier, S.9
Jicha, G.10
Meguro, K.11
O'Brien, J.12
Pasquier, F.13
Robert, P.14
Rossor, M.15
Salloway, S.16
Stern, Y.17
Visser, P.J.18
Scheltens, P.19
-
16
-
-
79956142378
-
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 263-269
-
-
McKhann, G.M.1
Knopman, D.S.2
Chertkow, H.3
Hyman, B.T.4
Jack Jr., C.R.5
Kawas, C.H.6
Klunk, W.E.7
Koroshetz, W.J.8
Manly, J.J.9
Mayeux, R.10
Mohs, R.C.11
Morris, J.C.12
Rossor, M.N.13
Scheltens, P.14
Carrillo, M.C.15
Thies, B.16
Weintraub, S.17
Phelps, C.H.18
-
17
-
-
62449262536
-
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
-
Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-389.
-
(2009)
Arch Neurol
, vol.66
, pp. 382-389
-
-
Tapiola, T.1
Alafuzoff, I.2
Herukka, S.K.3
Parkkinen, L.4
Hartikainen, P.5
Soininen, H.6
Pirttila, T.7
-
18
-
-
77949423619
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
-
Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144.
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 131-144
-
-
Blennow, K.1
Hampel, H.2
Weiner, M.3
Zetterberg, H.4
-
19
-
-
70350492571
-
Cerebrospinal fluid biomarkers for Alzheimer's disease
-
BlennowK, Zetterberg H (2009) Cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 18, 413-417.
-
(2009)
J Alzheimers Dis
, vol.18
, pp. 413-417
-
-
Blennow, K.1
Zetterberg, H.2
-
20
-
-
79957854917
-
Cerebrospinal fluid biomarkers for Alzheimer's disease: Diagnostic performance in a homogeneous mono-center population
-
Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Andreasson U, Zetterberg H, Blennow K, Svensson J (2011) Cerebrospinal fluid biomarkers for Alzheimer's disease: Diagnostic performance in a homogeneous mono-center population. J Alzheimers Dis 24, 537-546.
-
(2011)
J Alzheimers Dis
, vol.24
, pp. 537-546
-
-
Johansson, P.1
Mattsson, N.2
Hansson, O.3
Wallin, A.4
Johansson, J.O.5
Andreasson, U.6
Zetterberg, H.7
Blennow, K.8
Svensson, J.9
-
21
-
-
7444253126
-
Cerebrospinal Fluid Protein Biomarkers for Alzheimer's Disease
-
DOI 10.1602/neurorx.1.2.213, PII S1545534306700372, Biomarkers and Surrogates
-
Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1, 213-225. (Pubitemid 46589353)
-
(2004)
NeuroRx
, vol.1
, Issue.2
, pp. 213-225
-
-
Blennow, K.1
-
22
-
-
84856617005
-
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
-
Schoonenboom NS, Reesink FE, VerweyNA, Kester MI, Teunissen CE, van deVen PM, PijnenburgYA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78, 47-54.
-
(2012)
Neurology
, vol.78
, pp. 47-54
-
-
Schoonenboom, N.S.1
Reesink, F.E.2
Verwey, N.A.3
Kester, M.I.4
Teunissen, C.E.5
Van Deven, P.M.6
Pijnenburg, Y.A.7
Blankenstein, M.A.8
Rozemuller, A.J.9
Scheltens, P.10
Van Der Flier, W.M.11
-
23
-
-
84860191299
-
The 2008-2012 French Alzheimer plan: Description of the national Alzheimer information system
-
Le Duff F, Develay AE, Quetel J, Lafay P, Schuck S, Pradier C, Robert P (2012) The 2008-2012 French Alzheimer plan: Description of the national Alzheimer information system. J Alzheimers Dis 29, 891-902.
-
(2012)
J Alzheimers Dis
, vol.29
, pp. 891-902
-
-
Le Duff, F.1
Develay, A.E.2
Quetel, J.3
Lafay, P.4
Schuck, S.5
Pradier, C.6
Robert, P.7
-
24
-
-
0032988610
-
Mild cognitive impairment: Clinical characterization and outcome
-
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
-
(1999)
Archives of Neurology
, vol.56
, Issue.3
, pp. 303-308
-
-
Petersen, R.C.1
Smith, G.E.2
Waring, S.C.3
Ivnik, R.J.4
Tangalos, E.G.5
Kokmen, E.6
-
25
-
-
0034764622
-
Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on Frontotemporal Dementia and Pick's Disease
-
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58, 1803-1809. (Pubitemid 33044246)
-
(2001)
Archives of Neurology
, vol.58
, Issue.11
, pp. 1803-1809
-
-
McKhann, G.M.1
Albert, M.S.2
Grossman, M.3
Miller, B.4
Dickson, D.5
Trojanowski, J.Q.6
-
26
-
-
80052938441
-
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
-
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, PijnenburgY, ChowTW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477.
-
(2011)
Brain
, vol.134
, pp. 2456-2477
-
-
Rascovsky, K.1
Hodges, J.R.2
Knopman, D.3
Mendez, M.F.4
Kramer, J.H.5
Neuhaus, J.6
Van Swieten, J.C.7
Seelaar, H.8
Dopper, E.G.9
Onyike, C.U.10
Hillis, A.E.11
Josephs, K.A.12
Boeve, B.F.13
Kertesz, A.14
Seeley, W.W.15
Rankin, K.P.16
Johnson, J.K.17
Gorno-Tempini, M.L.18
Rosen, H.19
Prioleau-Latham, C.E.20
Lee, A.21
Kipps, C.M.22
Lillo, P.23
Piguet, O.24
Rohrer, J.D.25
Rossor, M.N.26
Warren, J.D.27
Fox, N.C.28
Galasko, D.29
Salmon, D.P.30
Black, S.E.31
Mesulam, M.32
Weintraub, S.33
Dickerson, B.C.34
Diehl-Schmid, J.35
Pasquier, F.36
Deramecourt, V.37
Lebert, F.38
Pijnenburg, Y.39
Chow, T.W.40
Manes, F.41
Grafman, J.42
Cappa, S.F.43
Freedman, M.44
Grossman, M.45
Miller, B.L.46
more..
-
27
-
-
0031672540
-
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
-
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
-
(1998)
Neurology
, vol.51
, pp. 1546-1554
-
-
Neary, D.1
Snowden, J.S.2
Gustafson, L.3
Passant, U.4
Stuss, D.5
Black, S.6
Freedman, M.7
Kertesz, A.8
Robert, P.H.9
Albert, M.10
Boone, K.11
Miller, B.L.12
Cummings, J.13
Benson, D.F.14
-
28
-
-
84880188930
-
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
-
McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB InternationalWorkshop. J Alzheimers Dis 9, 417-423. (Pubitemid 44253336)
-
(2006)
Journal of Alzheimer's Disease
, vol.9
, Issue.SUPPL. 3
, pp. 417-423
-
-
McKeith, I.G.1
-
29
-
-
70349243761
-
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population
-
van Rooden S, van der Grond J, van den Boom R, Haan J, Linn J, Greenberg SM, van Buchem MA (2009) Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 40, 3022-3027.
-
(2009)
Stroke
, vol.40
, pp. 3022-3027
-
-
Van Rooden, S.1
Van Der Grond, J.2
Van Den Boom, R.3
Haan, J.4
Linn, J.5
Greenberg, S.M.6
Van Buchem, M.A.7
-
30
-
-
84856962043
-
Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers
-
Slats D, Claassen JA, Spies PE, Borm G, Besse KT, Aalst WV, Tseng J, Sjogren MJ, Olde Rikkert MG, Verbeek MM (2011) Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers. Neurobiol Aging 33, 831.e1-e9.
-
(2011)
Neurobiol Aging
, vol.33
-
-
Slats, D.1
Claassen, J.A.2
Spies, P.E.3
Borm, G.4
Besse, K.T.5
Aalst, W.V.6
Tseng, J.7
Sjogren, M.J.8
Olde Rikkert, M.G.9
Verbeek, M.M.10
-
31
-
-
0023710206
-
Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
-
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44, 837-845.
-
(1988)
Biometrics
, vol.44
, pp. 837-845
-
-
Delong, E.R.1
Delong, D.M.2
Clarke-Pearson, D.L.3
-
32
-
-
67651204382
-
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
-
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosen E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttila T, Wallin A, Jonhagen ME, Minthon L, Winblad B, Blennow K (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393.
-
(2009)
JAMA
, vol.302
, pp. 385-393
-
-
Mattsson, N.1
Zetterberg, H.2
Hansson, O.3
Andreasen, N.4
Parnetti, L.5
Jonsson, M.6
Herukka, S.K.7
Van Der Flier, W.M.8
Ma, B.9
Ewers, M.10
Rich, K.11
Kaiser, E.12
Verbeek, M.13
Tsolaki, M.14
Mulugeta, E.15
Rosen, E.16
Aarsland, D.17
Visser, P.J.18
Schroder, J.19
Marcusson, J.20
De Leon, M.21
Hampel, H.22
Scheltens, P.23
Pirttila, T.24
Wallin, A.25
Jonhagen, M.E.26
Minthon, L.27
Winblad, B.28
Blennow, K.29
more..
-
33
-
-
65249159879
-
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
-
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413.
-
(2009)
Ann Neurol
, vol.65
, pp. 403-413
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
Clark, C.M.4
Aisen, P.S.5
Petersen, R.C.6
Blennow, K.7
Soares, H.8
Simon, A.9
Lewczuk, P.10
Dean, R.11
Siemers, E.12
Potter, W.13
Lee, V.M.14
Trojanowski, J.Q.15
-
34
-
-
81755177047
-
Evidence for ordering of Alzheimer disease biomarkers
-
Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS (2011) Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol 68, 1526-1535.
-
(2011)
Arch Neurol
, vol.68
, pp. 1526-1535
-
-
Jack Jr., C.R.1
Vemuri, P.2
Wiste, H.J.3
Weigand, S.D.4
Aisen, P.S.5
Trojanowski, J.Q.6
Shaw, L.M.7
Bernstein, M.A.8
Petersen, R.C.9
Weiner, M.W.10
Knopman, D.S.11
-
35
-
-
70349582720
-
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
-
Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ (2009) Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study. Neurology 73, 754-760.
-
(2009)
Neurology
, vol.73
, pp. 754-760
-
-
Okello, A.1
Koivunen, J.2
Edison, P.3
Archer, H.A.4
Turkheimer, F.E.5
Nagren, K.6
Bullock, R.7
Walker, Z.8
Kennedy, A.9
Fox, N.C.10
Rossor, M.N.11
Rinne, J.O.12
Brooks, D.J.13
-
36
-
-
0036338203
-
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231
-
DOI 10.1001/archneur.59.8.1267
-
Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttila T, Schapiro MB, Rapoport SI, Moller HJ, Davies P, Hampel H (2002) Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 59, 1267-1272. (Pubitemid 34856379)
-
(2002)
Archives of Neurology
, vol.59
, Issue.8
, pp. 1267-1272
-
-
Buerger, K.1
Zinkowski, R.2
Teipel, S.J.3
Tapiola, T.4
Arai, H.5
Blennow, K.6
Andreasen, N.7
Hofmann-Kiefer, K.8
DeBernardis, J.9
Kerkman, D.10
McCulloch, C.11
Kohnken, R.12
Padberg, F.13
Pirttila, T.14
Schapiro, M.B.15
Rapoport, S.I.16
Moller, H.-J.17
Davies, P.18
Hampel, H.19
-
37
-
-
0035261534
-
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies
-
DOI 10.1007/s100720170055
-
Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F (2001) CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau international study group. Neurol Sci 22, 77-78. (Pubitemid 33622091)
-
(2001)
Neurological Sciences
, vol.22
, Issue.1
, pp. 77-78
-
-
Parnetti, L.1
Lanari, A.2
Amici, S.3
Gallai, V.4
Vanmechelen, E.5
Hulstaert, F.6
-
38
-
-
9144257234
-
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosis of Alzheimer Disease: A Comparative Cerebrospinal Fluid Study
-
DOI 10.1001/archpsyc.61.1.95
-
Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K (2004) Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: A comparative cerebrospinal fluid study. Arch Gen Psychiatry 61, 95-102. (Pubitemid 38044645)
-
(2004)
Archives of General Psychiatry
, vol.61
, Issue.1
, pp. 95-102
-
-
Hampel, H.1
Buerger, K.2
Zinkowski, R.3
Teipel, S.J.4
Goernitz, A.5
Andreasen, N.6
Sjoegren, M.7
DeBernardis, J.8
Kerkman, D.9
Ishiguro, K.10
Ohno, H.11
Vanmechelen, E.12
Vanderstichele, H.13
McCulloch, C.14
Moller, H.-J.15
Davies, P.16
Blennow, K.17
-
39
-
-
49949152222
-
Cerebral amyloid angiopathy in Lewy body disease
-
Jellinger KA, Attems J (2008) Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm 115, 473-482.
-
(2008)
J Neural Transm
, vol.115
, pp. 473-482
-
-
Jellinger, K.A.1
Attems, J.2
-
40
-
-
57349155143
-
Posterior cortical atrophy: A rare form of dementia with in vivo evidence of amyloid-beta accumulation
-
Tenovuo O, Kemppainen N, Aalto S, Nagren K, Rinne JO (2008) Posterior cortical atrophy: A rare form of dementia with in vivo evidence of amyloid-beta accumulation. J Alzheimers Dis 15, 351-355.
-
(2008)
J Alzheimers Dis
, vol.15
, pp. 351-355
-
-
Tenovuo, O.1
Kemppainen, N.2
Aalto, S.3
Nagren, K.4
Rinne, J.O.5
-
41
-
-
70349884191
-
CSF biomarker levels in early and late onset Alzheimer's disease
-
Bouwman FH, Schoonenboom NS, Verwey NA, van Elk EJ, Kok A, Blankenstein MA, Scheltens P, van der Flier WM (2009) CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol Aging 30, 1895-1901.
-
(2009)
Neurobiol Aging
, vol.30
, pp. 1895-1901
-
-
Bouwman, F.H.1
Schoonenboom, N.S.2
Verwey, N.A.3
Van Elk, E.J.4
Kok, A.5
Blankenstein, M.A.6
Scheltens, P.7
Van Der Flier, W.M.8
-
42
-
-
65549102191
-
CSF biomarkers in Alzheimer's disease and controls: Associations with APOE genotype are modified by age
-
Kester MI, Blankenstein MA, Bouwman FH, van Elk EJ, Scheltens P, van der Flier WM (2009) CSF biomarkers in Alzheimer's disease and controls: Associations with APOE genotype are modified by age. J Alzheimers Dis 16, 601-607.
-
(2009)
J Alzheimers Dis
, vol.16
, pp. 601-607
-
-
Kester, M.I.1
Blankenstein, M.A.2
Bouwman, F.H.3
Van Elk, E.J.4
Scheltens, P.5
Van Der Flier, W.M.6
-
43
-
-
84858113047
-
Age and diagnostic performance of Alzheimer disease CSF biomarkers
-
Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jonhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 78, 468-476.
-
(2012)
Neurology
, vol.78
, pp. 468-476
-
-
Mattsson, N.1
Rosen, E.2
Hansson, O.3
Andreasen, N.4
Parnetti, L.5
Jonsson, M.6
Herukka, S.K.7
Van Der Flier, W.M.8
Ma, B.9
Ewers, M.10
Rich, K.11
Kaiser, E.12
Verbeek, M.M.13
Olde Rikkert, M.14
Tsolaki, M.15
Mulugeta, E.16
Aarsland, D.17
Visser, P.J.18
Schroder, J.19
Marcusson, J.20
De Leon, M.21
Hampel, H.22
Scheltens, P.23
Wallin, A.24
Eriksdotter-Jonhagen, M.25
Minthon, L.26
Winblad, B.27
Blennow, K.28
Zetterberg, H.29
more..
-
44
-
-
0034650710
-
Mild cognitive impairment: Conceptual basis and current nosological status
-
Ritchie K, Touchon J (2000) Mild cognitive impairment: Conceptual basis and current nosological status. Lancet 355, 225-228. (Pubitemid 30068229)
-
(2000)
Lancet
, vol.355
, Issue.9199
, pp. 225-228
-
-
Ritchie, K.1
Touchon, J.2
-
45
-
-
78349287910
-
The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia
-
Spies PE, Slats D, Sjogren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM (2010) The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr Alzheimer Res 7, 470-476.
-
(2010)
Curr Alzheimer Res
, vol.7
, pp. 470-476
-
-
Spies, P.E.1
Slats, D.2
Sjogren, J.M.3
Kremer, B.P.4
Verhey, F.R.5
Rikkert, M.G.6
Verbeek, M.M.7
|